Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enhance MD vs Obu Health

By GLP-1 ScorecardUpdated

Enhance MD
Site position #4

Higher grade

Obu Health
Site position #378

Lower grade

Score comparison

Enhance MD has the higher recorded score — 84.8/100 to 59.9/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEnhance MD +38
82
44
Dose & formulationEnhance MD +18
82
64
Clinical oversightEnhance MD +4
88
84
Labs & monitoringEnhance MD +37
90
53
FulfillmentEnhance MD +10
84
74
Contract termsEnhance MD +53
84
31
Enhance MD · top barObu Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEnhance MDObu Health
WeighScore84.8/10059.9/100
GradeBC
Site position#4#378
Semaglutide$249 every 4 weeks on the shortest Core plan; from $212 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge)$190/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$329 every 4 weeks on the shortest Advanced plan; from $280 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge)$239/mo (starting dose, plus a separate fee, compounded)
CoverageFAQ lists 40 states plus DC, subject to product availability; confirm treatment, clinician and pharmacy for your addressCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Enhance MD

Site position #4 · B

Strengths

  • Core and Advanced publish separate short- and longer-plan prices with billing periods stated
  • Product pages advertise care, coaching, supplies and six-month labs; baseline labs are described in onboarding
  • Terms identify independent medical groups and possible pharmacies rather than only a generic provider network
  • The FAQ publishes a product-availability state list and a clinical-ineligibility initial-payment refund policy

What to consider

  • Four-week billing and a 48-week longer plan are not twelve calendar-month payments
  • First-order discounts differ by term; actual debit, dose, quantity and ongoing schedule require confirmation
  • An unused-prepaid-balance refund formula and precise refill cancellation cutoff were not established
  • Pharmacy lists differ across public documents; the assigned dispenser and prescriber remain unknown
  • One disclosed pharmacy has a closed Oklahoma nonresident permit; this limited finding does not establish company closure or the pharmacy assigned to a patient
  • Elite combination and microdose benefit claims were not independently established; no branded or oral GLP-1 offer was established in the reviewed menu
Obu Health

Site position #378 · C

Strengths

  • LegitScript-certified with publicly displayed ID (44206977)
  • Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
  • Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
  • Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
  • 24-hour US board-certified physician response window

What to consider

  • Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
  • No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
  • Medical director not named publicly
  • No published consultation fee disclosure — unclear whether physician visit is included in medication price
  • All sales final per FAQ ('Federal and State law do not allow medication returns')

Featured provider

Enhance MD

Enhance MD scores 84.8/100 (B). Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard